Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Zou, Guichenga; 1 | Wang, Ruib; 1; * | Wang, Minghuic
Affiliations: [a] Department of General Surgery, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong, China | [b] Department of Anorectal, Yantai Hospital of Traditional Chinese Medicine, Yantai, Shandong, China | [c] Department of Clinical Laboratory, Yantai Wanhua Hospital, Yantai, Shandong, China
Correspondence: [*] Corresponding author: Rui Wang, Department of Anorectal, Yantai Hospital of Traditional Chinese Medicine, Zhifu District, Yantai 264000, Shandong, China. Tel.: +86 535 6597156; E-mail: [email protected].
Note: [1] Contributed equally.
Abstract: BACKGROUND: Colorectal cancer (CRC) is a common type of cancer around the world. Detection of microRNA (miRNA) aberration in blood samples is a novel approach for CRC screening. OBJECTIVE: The purpose of this study was to explore the serum miR-497 expression pattern in CRC and examine its potential usefulness as a biomarker for CRC diagnosis and prognosis. METHODS: Serum miR-497 expression was evaluated by quantitative reverse transcription polymerase chain reaction (qRT-PCR) in 110 patients with CRC, 35 cases with colorectal adenoma, 54 cases with colorectal polyps, and 70 healthy individuals. RESULTS: The expression level of miR-497 was significantly downregulated in CRC tissues compared to the normal tissues based on the data from three independent studies GSE68204, GSE41655 and GSE35834. Compared to healthy controls, the serum miR-497 level was significantly decreased in patient with CRC or benign lesion (colorectal adenoma and polyps). Serum miR-497 level was dramatically increased in the post-operative blood samples from early stage CRC patients. Receiver-operating characteristic (ROC) analysis showed that serum miR-497 had a high sensitivity and specificity for discriminating CRC or precancerous colorectal lesion from normal controls. Moreover, low serum miR-497 expression was closely correlated with aggressive clinical features and shorter overall survival (OS). Kaplan-Meier analyses also revealed that OS was strongly associated with lymph node invasion, TNM stage and histological grade. Furthermore, univariate and multivariate analysis showed serum miR-497 was an independent prognostic factor for CRC. CONCLUSIONS: Collectively, serum miR-497 may serve as a promising biomarker for diagnosis and prognosis of CRC.
Keywords: Colorectal cancer, biomarker, serum miR-497, prognosis
DOI: 10.3233/CBM-181902
Journal: Cancer Biomarkers, vol. 25, no. 1, pp. 11-18, 2019
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]